FindTrial
Sign In

CLINICAL TRIAL ON NEERIZHIVU[DIABETES MELLITUS] WITH YOGA

An open labelled non- randomized phase II comparative clinical trial to evaluate the therapeutic efficacy of SIDDHAR YOGAM THERAPY and NAAVAL PAZHA KARPAM [ SIDDHA KALPA MEDICINE-INTERNAL] for NEERIZHIVU[DIABETES MELLITUS]

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019749
Enrollment
40
Registered
2019-06-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: SIDDHAR YOGAM THERAPY WITH NAAVAL PAZHA CHOORANAM: SIDDHAR YOGAM THERAPY AND NAAVAL PAZHA CHOORANAM 1-2 GRAMS FOR 48 DAYS Control Intervention1: nil: nil

Sponsors

H JESIMA BARVEEN
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients with the symptoms of diabetes mellitus not more than 2 years are included patient willing to give blood and urine samples before and after treatment patient with blood sugar level of about more than 126mg/dl less than 250 mg/dl Hba1c more than 6.5 and less than 10 willing to participate in study and signing consent by fulfiling the condition of proforma are included

Exclusion criteria

Exclusion criteria: Age group less than 35 chronic diabeic cases for duration more than 2 years Ischaemic heart disease Diabetic foot and ulcer Gestational diabetes mellitus/other specific types Lactating mother Chronic liver disease chronic renal disease

Design outcomes

Primary

MeasureTime frame
The outcome is assessed by the reduction of blood sugar level after treatmentTimepoint: Group I intermittent siddhar yogam therapy for 48 days Ist sitting 40 percentage of primary symptoms will reduce IInd sitting 80 percentage of symptoms will reduce Group II After giving internal medicine for 48 days 50 percentage of symptoms will reduce After giving both internal medicine and external therapy for 48 days 80 percentage of symptoms will reduce—

Secondary

MeasureTime frame
The outcome is assessed by the reduction of blood sugar level after treatmentTimepoint: Group I intermittent siddhar yogam therapy for 48 days Ist sitting 40 percentage of primary symptoms will reduce IInd sitting 80 percentage of symptoms will reduce Group II After giving internal medicine for 48 days 50 percentage of symptoms will reduce After giving both internal medicine and external therapy for 48 days 80 percentage of symptoms will reduce—

Countries

India

Contacts

Public ContactA S POONGODI KANTHIMATHI

Govt Siddha Medical College Hospital

arunapriya1995@gmail.com9865105356

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026